Stifel Financial’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-15,081
| Closed | -$41.8K | – | 3408 |
|
2024
Q1 | $41.8K | Sell |
15,081
-10,707
| -42% | -$29.7K | ﹤0.01% | 3268 |
|
2023
Q4 | $43.8K | Sell |
25,788
-7,425
| -22% | -$12.6K | ﹤0.01% | 3232 |
|
2023
Q3 | $34.2K | Buy |
33,213
+150
| +0.5% | +$155 | ﹤0.01% | 3210 |
|
2023
Q2 | $38.4K | Sell |
33,063
-1,596
| -5% | -$1.85K | ﹤0.01% | 3253 |
|
2023
Q1 | $52.3K | Sell |
34,659
-1,222
| -3% | -$1.85K | ﹤0.01% | 3231 |
|
2022
Q4 | $89.7K | Sell |
35,881
-11,298
| -24% | -$28.2K | ﹤0.01% | 3147 |
|
2022
Q3 | $199K | Sell |
47,179
-428
| -0.9% | -$1.81K | ﹤0.01% | 2958 |
|
2022
Q2 | $133K | Sell |
47,607
-1,720
| -3% | -$4.81K | ﹤0.01% | 3109 |
|
2022
Q1 | $282K | Sell |
49,327
-2,711
| -5% | -$15.5K | ﹤0.01% | 2907 |
|
2021
Q4 | $475K | Sell |
52,038
-11,822
| -19% | -$108K | ﹤0.01% | 2616 |
|
2021
Q3 | $683K | Sell |
63,860
-25,506
| -29% | -$273K | ﹤0.01% | 2380 |
|
2021
Q2 | $1.39M | Buy |
89,366
+2,241
| +3% | +$34.8K | ﹤0.01% | 1857 |
|
2021
Q1 | $1.41M | Buy |
87,125
+13,166
| +18% | +$213K | ﹤0.01% | 1751 |
|
2020
Q4 | $1.57M | Sell |
73,959
-5,909
| -7% | -$125K | ﹤0.01% | 1539 |
|
2020
Q3 | $1.18M | Buy |
79,868
+407
| +0.5% | +$6.03K | ﹤0.01% | 1519 |
|
2020
Q2 | $1.17M | Sell |
79,461
-65,274
| -45% | -$960K | ﹤0.01% | 1450 |
|
2020
Q1 | $1.69M | Buy |
144,735
+14,745
| +11% | +$172K | ﹤0.01% | 1130 |
|
2019
Q4 | $3.05M | Buy |
129,990
+20,670
| +19% | +$484K | 0.01% | 1095 |
|
2019
Q3 | $2.04M | Buy |
109,320
+859
| +0.8% | +$16K | 0.01% | 1302 |
|
2019
Q2 | $2.03M | Buy |
108,461
+51,658
| +91% | +$965K | 0.01% | 1324 |
|
2019
Q1 | $1.37M | Buy |
+56,803
| New | +$1.37M | ﹤0.01% | 1470 |
|
2018
Q3 | – | Sell |
-28,134
| Closed | -$1.09M | – | 2785 |
|
2018
Q2 | $1.09M | Buy |
+28,134
| New | +$1.09M | ﹤0.01% | 1554 |
|